Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-10

Clinical Trial Update: A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating SAR441566 in adults with plaque psoriasis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SAR441566 (SAR441566)

Snippet

Sponsor: Sanofi | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2025-11-10